Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Lazard Inc. (LAZ)

NYSE: LAZ · Investment Advice · New York, NY

Our rating: Neutral

Neutral reaffirmed at $38.17, moderate conviction, October 27, 2026.

Breaks if: Neutral becomes Positive if revenue growth re-accelerates to 8% or above year-over-year in two consecutive quarterly filings, signaling a genuine M&A advisory cycle recovery that starts to earn the P/B. Neutral becomes Cautious if reported ROE falls below 18% over the next two quarterly periods, or if reported revenue declines year-over-year in two consecutive quarters — either condition would mean the franchise is eroding faster than a 4.83× P/B can tolerate.

Key figures

Market value$3.9B
Revenue, last 12 months$3.4B
Net income, last 12 months$185M
Free cash flow, last 12 months$685M
Price to earnings21.1×
Free cash flow yield17.5%
Dividend yield5.6%
Operating margin7.9%
Return on equity20.6%
Beta to the S&P 5001.68
Volatility, annualized43.2%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$836M8.5%$0.26$311M
June 30, 2026$830M1.6%$0.03$199M
March 31, 2026$779M16.5%$0.91−$221M
December 31, 2025$929M10.8%$0.45$396M
September 30, 2025$771M−4.5%$0.65$285M
June 30, 2025$817M15.4%$0.52$38M
March 31, 2025$669M−14.8%$0.56−$231M
December 31, 2024$839M1.6%$0.80$348M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

10 ledger entries and 44 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.